3264-38-8 Usage
Uses
Used in Pharmaceutical Industry:
1-Acetyl-5-indolinesulfonamide is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, potentially contributing to advancements in medicine.
Used in Research and Development:
1-Acetyl-5-indolinesulfonamide is used as a research compound in the field of organic chemistry. It serves as a model compound for studying the properties and reactions of indolines, which can lead to a better understanding of their potential applications in various industries.
Used in Chemical Synthesis:
1-Acetyl-5-indolinesulfonamide is used as a starting material in the synthesis of other organic compounds. Its reactivity and structural features make it a valuable component in the creation of new chemical entities, which can be used in a wide range of applications, from pharmaceuticals to materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 3264-38-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,2,6 and 4 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3264-38:
(6*3)+(5*2)+(4*6)+(3*4)+(2*3)+(1*8)=78
78 % 10 = 8
So 3264-38-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O3S/c1-7(13)12-5-4-8-6-9(16(11,14)15)2-3-10(8)12/h2-3,6H,4-5H2,1H3,(H2,11,14,15)
3264-38-8Relevant academic research and scientific papers
SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS
-
Page/Page column 141-142, (2012/12/13)
Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.
Indole-sulfonamides as antitumor agents
-
, (2008/06/13)
This invention provides certain indolinesulfonamide and substituted-indolesulfonamide derivatives of the formula wherein: R1 is C1-C6 alkyl;, R2 and R3 are independently selected from the group consisting of hydrogen, halo, C1-C6 alkyl, and trifluoromethyl, provided that no more than one of R2 and R3 can be hydrogen;, and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these indolinesulfonamide and substituted-indolesulfonamide derivatives in combination with a carrier, excipient or diluent, as well as processes for preparing the compounds.
